期刊文献+

干扰素和小剂量阿糖胞苷联合作用诱导K562细胞凋亡 被引量:4

Mechanisms of Apoptosis of K562 Cells Induced by Interferon alpha-2b Combined with Low-dose Cytarabine
暂未订购
导出
摘要 目的研究干扰素(IFN)和小剂量阿糖胞苷(Ara-C)联合应用对K562细胞的诱导凋亡作用,并探讨其机制。方法以IFN-α2b和小剂量Ara-C单独和联合作用后,MTT法检测K562细胞的生长抑制率,流式细胞仪检测细胞凋亡水平,RT-PCR检测野生型p53基因的表达,免疫细胞化学法检测野生型P53蛋白的表达。结果IFN-α2b和小剂量Ara-C联合作用可以有效抑制K562细胞的增殖,联合作用后K562细胞的抑制率可达42.85%,与对照组及单用IFN-α2b和单用Ara-C相比,差异均有显著性意义(均P<0.05)。IFN-α2b和小剂量Ara-C联合作用72 h后,可以使K562细胞凋亡率提高到39.03%,与对照组及单用IFN-α2b和单用Ara-C相比,差异均有显著性意义(均P<0.05)。两药联合作用可以促进野生型p53基因mRNA和蛋白的表达上调。结论联合使用IFN和小剂量Ara-C可以协同诱导K562白血病细胞的凋亡,促进野生型p53基因和蛋白表达上调可能是其机制之一。 Objective To investigate the mechanisms of apoptosis of K562 induced by interferon (IFN) combined with low-dose cytarabine-C (Ara-C). Methods K562 cells were treated with IFN-α 2b and low-dose Ara-C. The growth inhibitory rate was detected by MTT, apoptosis by flow cytometry, the expression of wide type p53 mRNA by RT-PCR, and the expression of wide type P53 protein by immunocytochemistry. Results After treated with IFN-α 2b and low-dose Ara-C, the inhibitory rate of K562 cells, compared with that in the control, was increased to 42.85 %, and the apoptotic rate of K562 cells was increased from 3.88 % to 39.03 %. Apoptosis of K562 was accompanied by the expression of wide type p53 mRNA and protein. The transcription of the p53 gene was induced by IFN-α 2b and low-dose Ara-C, accompanied by an increase in P53 protein level. Conclusion IFN combined with low-dose Ara-C can induce apoptosis of K562 cells. Wide type p53 is contributed to the apoptosis of the cells induced by IFN combined with low-dose Ara-C.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2006年第3期336-338,342,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 湖北省卫生厅重点科研基金资助项目(No.JX2A10)
关键词 干扰素 阿糖胞苷 K562细胞 细胞凋亡 interferon cytarabine K562 cell apoptosis
  • 相关文献

参考文献9

  • 1GORDON M Y, MARLEY S B, LEWIS J L, et al. Treatment with interferon-α preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFUGM) from patients with chronic myeloid leukemia but spares normal CFU-GM[J]. J Clin Invest, 1998, 102(4) : 710-715.
  • 2MOSHE T, ASHOK R, KAREN R, et al. Phase Ⅰ evaluation of a 40 kD branched-chain long-acting pegylated IFN-α 2a with and without cytarabine in patients with chronic myelogenous leukemia[J]. Clin Cancer Res, 2005, 11(17): 6247-6255.
  • 3HECKER K H, ROUX K H. High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR[J]. Biotechniques, 1996, 20(3):478-485.
  • 4NAKAMURA Y. Isolation of P53-target genes and their functional analysis[J]. Cancer Sci, 2004, 95(1):7-11.
  • 5TOKINO T, NAKAMURA Y. The role of P53-target genes in human cancer[J]. Crit Rev Oncol Hematol, 2000,33 (1) :1-6.
  • 6MILNER J. A conformation hypothesis for the suppressor and promoter functions of P53 in cell growth control and in cancer[J]. Proc R Soc Lond B Biol Sci, 1991, 245(1313) : 139-145.
  • 7SANCAR A, LINDSEY-BOLTZ L A, UNSAL KACMAZ K,et al. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints[J]. Annu Rev Biochem, 2004,73: 39-85.
  • 8PORTA C, HADJ-SLIMANE R, NEJMEDDINE M, et al.Interferons alpha and gamma induce P53-dependent and P53-independent apoptosis, respectively[J]. Oncogene, 2005, 24(4) : 605-615.
  • 9TAKAOKA A, HAYAKAWA S, YANAI H, et al. Integration of interferon alpha/beta signalling to P53 responses in tumour suppression and antiviral defence[J]. Nature, 2003,424(6948) : 516-523.

同被引文献72

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部